• Exergen

Exergen Corporation Expands into Austria

Signs marketing and distribution agreement with Balmung Medical Handel for the full line of non-invasive high-tech thermometers for hospitals and healthcare institutions Exergen Corporation, a global leader in infrared temperature measurement technologies for medical applications, announced today that it has signed a marketing and distribution contract with Balmung Medical Handel to market the TAT-5000S professional Temporal Artery Thermometers in Austria. “Balmung Medical Handel is based in Vienna, Austria”, says Thomas Heger, Head Strategy Procurement Balmung. “Our company was founded in [...]

By |2021-02-04T07:17:33+00:00January 17th, 2021|News|Comments Off on Exergen Corporation Expands into Austria
  • organogenesis

Organogenesis Enrolls First Patient in Pivotal Phase 3 Clinical Trial of RMAT-Designated ReNu® for Knee Osteoarthritis

CANTON, Mass., January 14, 2021 – Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that the first patient has been enrolled in its pivotal Phase 3 clinical trial evaluating the safety and efficacy of ReNu®, a cryopreserved amniotic suspension allograft (ASA), for the management of symptoms associated with knee osteoarthritis (OA). Read more: Organogenesis Enrolls [...]

By |2021-02-04T08:18:49+00:00January 14th, 2021|News|Comments Off on Organogenesis Enrolls First Patient in Pivotal Phase 3 Clinical Trial of RMAT-Designated ReNu® for Knee Osteoarthritis
  • Exergen

Exergen Corporation Delivers on its Mission to Meet Thermometer Demand – Because Accuracy Matters

New Campaigns Incentivize People to Trade-In Their Non-Contact Thermometers; Motivate Employers to Protect Nurses, and Educate Consumers About Twice Daily Temperature Taking at Home Since COVID-19 hit nearly a year ago, Exergen Corporation’s mission has been to meet the unprecedented demand for an accurate thermometer. The company has accomplished this by making the production of its thermometers, the #1 thermometers sold nationwide, its top priority and by opening a second, much larger, U.S. manufacturing facility, to dramatically expand its production [...]

By |2021-02-04T07:06:03+00:00January 12th, 2021|News|Comments Off on Exergen Corporation Delivers on its Mission to Meet Thermometer Demand – Because Accuracy Matters
  • organogenesis

Organogenesis ReNu® Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For Osteoarthritis of the Knee

CANTON, Mass., January 11, 2021 – Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that the U.S. Food and Drug Administration (FDA) has granted ReNu®, a cryopreserved amniotic suspension allograft for the management of symptoms associated with knee osteoarthritis (OA), Regenerative Medicine Advanced Therapy (RMAT) designation.   Read more: Organogenesis ReNu® Receives FDA Regenerative Medicine [...]

By |2021-02-04T08:22:23+00:00January 11th, 2021|News|Comments Off on Organogenesis ReNu® Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For Osteoarthritis of the Knee
  • Dynasil

Dynasil Appoints Militram Futuristic Technologies to Target Israel’s Fast Growing Industrial, Commercial and Military Segments

Dynasil Corporation of America ("Dynasil" or the "Company"), a leading developer and manufacturer of optics and photonics products, optical detection and analysis technology and components for homeland security, medical and industrial markets, today announces that it has appointed Militram Futuristic Technologies of Israel to pursue the growing demand in Israel’s industrial, commercial and military segments.   Read more: Dynasil Appoints Militram Futuristic Technologies to Target Israel’s Fast Growing Industrial, Commercial and Military Segments | Dynasil Corporation   

By |2021-02-04T08:34:18+00:00January 7th, 2021|News|Comments Off on Dynasil Appoints Militram Futuristic Technologies to Target Israel’s Fast Growing Industrial, Commercial and Military Segments
  • Vero

VERO Biotech Named Top Two Stories of 2020 by Pulmonary Hypertension News

The first person with coronavirus disease 2019 (COVID-19) complicating pulmonary hypertension (PH) has received at-home treatment with inhaled nitric oxide (iNO), delivered through the Genosyl system, according to VERO Biotech, manufacturer of Genosyl. Read more: https://pulmonaryhypertensionnews.com/2020/03/25/covid-19-patient-with-ph-treated-with-ino-via-genosyl-vero-biotech-announces/

By |2021-02-04T08:54:44+00:00January 5th, 2021|News|Comments Off on VERO Biotech Named Top Two Stories of 2020 by Pulmonary Hypertension News

Aquent mobilizes for social justice

Company, staff, talent, and clients donate to NAACP Legal Defense and Educational Fund.   In the wake of the killings of George Floyd, Breonna Taylor, and too many others, Aquent committed to donating $20,000 to the NAACP Legal Defense and Educational Fund, and also matched donations, dollar for dollar, made by staff, registered talent, and clients. According to John Chuang, Aquent CEO, it was a move to “to reaffirm our company’s values” at an urgent time. Chuang said Aquent was [...]

By |2021-02-04T08:39:05+00:00December 17th, 2020|News|Comments Off on Aquent mobilizes for social justice
  • Pure Incubation

Demand Science Announces 6th Consecutive Year of Double-Digit Revenue Growth and Expansion of Leadership Team as Company Positions for 2021 Acceleration

Company's Organic Revenue Growth Has Fueled 48% CAGR from 2014 through 2020, New Members of Exec Team Include Chief Data Officer from Google and DataFoundry, President of PureB2B Division, and GM for its U.S. Analytics Business DANVERS, Mass., December 16, 2020 (Newswire.com) - Demand Science, a global buyer intelligence platform and integrated B2B solution suite that drives sales and marketing growth for hundreds of the world's largest technology and B2B companies, today announced it has achieved its sixth consecutive year [...]

By |2021-02-04T08:52:28+00:00December 16th, 2020|News|Comments Off on Demand Science Announces 6th Consecutive Year of Double-Digit Revenue Growth and Expansion of Leadership Team as Company Positions for 2021 Acceleration
  • Exergen

Exergen Corporation Expands into Spain with Galmedica as a New Distributor

Galmedica will Sell and Support a Full Line of Non-Invasive High-Tech Thermometers for use in Hospitals and Healthcare Institutions Exergen Corporation, a global leader in infrared temperature measurement technologies for medical applications, announced today that it has signed an agreement with Galmedica for the distribution of its full line of Temporal Artery Thermometers in Spain. “With a highly advanced healthcare system Spain is a significant region within Europe”, says Dr. Joaquin Azpilicueta M.D., Exergen’s Sales Director Europe and LATAM. “Galmedica [...]

By |2021-02-04T07:11:11+00:00December 4th, 2020|News|Comments Off on Exergen Corporation Expands into Spain with Galmedica as a New Distributor
  • Dynasil

RMD’s CLLBC Technology Successfully Integrated in Kromek’s Award-Winning RIID

Dynasil Corporation of America (“Dynasil” or the “Company”), a leading developer and manufacturer of optics and photonics products, optical detection and analysis technology and components for the homeland security, medical and industrial markets, today announces that CLLBC, a product of its subsidiary RMD, Inc, has been successfully integrated in Kromek’s M2R2 CLLBC Multimode Radioisotope Identification Detector (RIID) aka D5 RIID.  Kromek recently received the prestigious 2020 R&D100 Award for this new RIID.   Read more: RMD’s CLLBC Technology Successfully Integrated [...]

By |2021-02-04T08:31:21+00:00December 1st, 2020|News|Comments Off on RMD’s CLLBC Technology Successfully Integrated in Kromek’s Award-Winning RIID